We are live on ! Find out more
CHTP

CHELSEA THERAPEUTICS INT'L LTD
CHTP

Delisted

CHTP was delisted on the 23rd of June, 2014.

6 hedge funds and large institutions have $4.84M invested in CHELSEA THERAPEUTICS INT'L LTD in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more call options, than puts

Call options by funds: $13.8M | Put options by funds: $2.87M

93% less funds holding

Funds holding: 856 (-79)

98% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 81

98% less capital invested

Capital invested by funds: $204M → $4.84M (-$199M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
6
Holders Change
-79
Holders Change %
-92.94%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
Reduced
4
Closed
81
Calls
$13.8M
Puts
$2.87M
Net Calls
+$10.9M
Net Calls Change
+$4.71M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
51
Goldman Sachs
New York
-$294K -53,345 Closed
ARC
52
Absolute Return Capital
Massachusetts
-$290K -52,467 Closed
Citadel Advisors
53
Citadel Advisors
Florida
-$276K -49,962 Closed
AllianceBernstein
54
AllianceBernstein
Tennessee
-$272K -49,230 Closed
Morgan Stanley
55
Morgan Stanley
New York
-$270K -48,857 Closed
PAM
56
Panagora Asset Management
Massachusetts
-$254K -46,017 Closed
Bank of America
57
Bank of America
North Carolina
-$216K -39,049 Closed
Renaissance Technologies
58
Renaissance Technologies
New York
-$184K -33,306 Closed
SG Americas Securities
59
SG Americas Securities
New York
-$153K -27,732 Closed
AGM
60
Alpine Global Management
New York
-$144K -26,000 Closed
VKH
61
Virtu KCG Holdings
New York
-$142K -25,651 Closed
PAAMCP
62
Pacific Alternative Asset Management Company (PAAMCO)
California
-$141K -25,536 Closed
FMA
63
FNY Managed Accounts
New York
-$138K -25,000 Closed
ID
64
Integral Derivatives
New York
-$137K -24,790 Closed
Nomura Holdings
65
Nomura Holdings
Japan
-$127K -22,649 Closed
Tudor Investment Corp
66
Tudor Investment Corp
Connecticut
-$112K -20,365 Closed
Citigroup
67
Citigroup
New York
-$112K -18,966 -100%
JG
68
Jefferies Group
New York
-$79K -14,400 Closed
QIM
69
Quantitative Investment Management
Virginia
-$77K -14,100 Closed
Connor, Clark & Lunn Investment Management (CC&L)
70
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$82K -13,400 Closed
TAM
71
Telluride Asset Management
Minnesota
-$70K -12,747 Closed
GA
72
Gateway Advisory
New Jersey
-$69K -12,500 Closed
Bank of Montreal
73
Bank of Montreal
Ontario, Canada
-$60K -10,809 Closed
T
74
TradeWorx
New Jersey
-$58K -10,548 Closed
PA
75
Profund Advisors
Maryland
-$56K -10,200 Closed

CHTP Hedge Fund Activity: Q2 2014 in Review

6 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in CHELSEA THERAPEUTICS INT'L LTD (CHTP) for Q2 2014, worth a combined $4.84M — down 98% from $204M a quarter earlier.

Sellers outnumbered buyers: 81 funds closed out of CHTP and 2 opened new positions — a net loss of 79 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was Whitebox Advisors, opening a new position worth an estimated $16.4M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $37.3M sold.

  • 6 institutional investors held CHELSEA THERAPEUTICS INT'L LTD (CHTP) as of Q2 2014, down from 85 in Q1 2014.
  • Funds reported $4.84M of CHELSEA THERAPEUTICS INT'L LTD stock for Q2 2014, down 98% quarter-over-quarter.
  • 2 funds opened new CHELSEA THERAPEUTICS INT'L LTD positions in Q2 2014 and 81 closed out, a net change of -79 holders.
  • The largest CHELSEA THERAPEUTICS INT'L LTD buyer in Q2 2014 was Whitebox Advisors, an estimated $16.4M added.
  • The largest CHELSEA THERAPEUTICS INT'L LTD seller in Q2 2014 was Baker Bros. Advisors, an estimated $37.3M sold.

Based on aggregated 13F filings for Q2 2014.